Calmare Therapeutics Inc (fka CTTC)

[powderbum]

Pretty darn impressive

http://www.mattioli1885.com/onlinejournals/index.php/actabiomedica/article/view/4306/3288

Table 3. Degree of pain relief achieved at each center
Pain NRS NRS N Pain Relief
Center Before end cycle >=50%
1 7,06 1,63 65 87.69%
2 9,4 2,8 5 80.0%
3 7,65 2,24 29 72.41%
4 7,77 0,77 45 97.77%
5 6,63 2,09 11 81.81%
6 7,5 1,75 4 75.00%
7 7,5 3,4 10 50.0%
8 6,15 0,53 13 92.30%
9 8,15 1,68 19 84.21%

Conclusion
ST is an efficient and safe alternative for several
different types of refractory chronic neuropathic pain,
with a very rare possibility of adverse events. A high
percentage of patients suffering neuropathic pain obtained
a sustained relief in different clinical settings.
It is important to highlight that for the nature of this
research, this data represent in the opinion of the authors, a trustworthy snapshot of the ST results in the
current clinical experience.